Pfizer's Super Bowl ad received mixed reactions on social media, but many criticized the pharma giant for saying it will ...

Topline data were announced from a phase 3 trial evaluating Keytruda plus Lenvima with chemotherapy in advanced gastroesophageal cancer.

Seven months into her latest tenure with Moffitt Cancer Center as senior vice president and chief informatics and technology ...

Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...

Disease-free survival as a surrogate endpoint for overall survival in adults with early-stage pancreatic cancer: A trial-level surrogacy analysis. This is an ASCO Meeting Abstract from the 2025 ASCO ...

The American Cancer Society's annual trend report is out with some mixed results. Cancer deaths are down but cases among certain groups are up. Jamil Rivers, a South Jersey mother of two ...

At the final analysis, the coprimary endpoint of overall survival was not met. Topline data were announced from a phase 3 trial evaluating pembrolizumab (Keytruda ®) plus lenvatinib (Lenvima ...

Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...

There is a unique group of tumors, called 'mixed tumors', which can arise from the seminal vesicles; as the name implies, these are composed of a mixture of epithelial and stromal elements.

From opportunities and challenges to personal growth and relationships, discover what the stars have in store for you tomorrow.